HEADER OXIDOREDUCTASE 13-MAR-00 1EL9 TITLE COMPLEX OF MONOMERIC SARCOSINE OXIDASE WITH THE INHIBITOR TITLE 2 [METHYLTHIO]ACETATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SARCOSINE OXIDE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.5.3.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS SP.; SOURCE 3 ORGANISM_TAXID: 69000; SOURCE 4 STRAIN: B-0618; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_CELL: DH1 CELLS KEYWDS FLAVOPROTEIN, OXIDASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.A.WAGNER,P.TRICKEY,Z.-W.CHEN,F.S.MATHEWS,M.S.JORNS REVDAT 5 04-OCT-17 1EL9 1 REMARK REVDAT 4 13-JUL-11 1EL9 1 VERSN REVDAT 3 24-FEB-09 1EL9 1 VERSN REVDAT 2 01-APR-03 1EL9 1 JRNL REVDAT 1 06-DEC-00 1EL9 0 JRNL AUTH M.A.WAGNER,P.TRICKEY,Z.W.CHEN,F.S.MATHEWS,M.S.JORNS JRNL TITL MONOMERIC SARCOSINE OXIDASE: 1. FLAVIN REACTIVITY AND ACTIVE JRNL TITL 2 SITE BINDING DETERMINANTS. JRNL REF BIOCHEMISTRY V. 39 8813 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10913292 JRNL DOI 10.1021/BI000349Z REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.TRICKEY,M.A.WAGNER,M.S.JORNS,F.S.MATHEWS REMARK 1 TITL MONOMERIC SARCOSINE OXIDASE: STRUCTURE OF A COVALENTLY REMARK 1 TITL 2 FLAVINYLATED AMINE OXIDIZING ENZYME REMARK 1 REF STRUCTURE V. 7 331 1999 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(99)80043-4 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.9 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 500.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.6 REMARK 3 NUMBER OF REFLECTIONS : 43663 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 4474 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6016 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 552 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.680 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EL9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1000010701. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUL-98 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43804 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 500.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.08800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 53.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.55 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: REFINED DIRECTLY REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: MAD PHASING WAS NOT USED TO SOLVE 1EL9 AND 1ELI, BUT REMARK 200 RATHER DIRECT REFINEMENT AS THE CRYSTALS WERE ISOMORPHOUS ENOUGH REMARK 200 TO THE NATIVE REMARK 200 CRYSTALS FOR PHASING. SELENOMETHIONINE CRYSTALS WERE USED FOR THE REMARK 200 EXPERIMENTS SINCE THEY WERE THE ONLY ONES ON HAND AT THE TIME. REMARK 200 KINETIC STUDIES SHOWED THAT THE PRESENCE OF SELENOMETHIONINE HAD REMARK 200 LITTLE EFFECT. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PHOSPHATE, TRIS-HCL, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.79350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS MONOMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 386 REMARK 465 THR A 387 REMARK 465 THR A 388 REMARK 465 ILE A 389 REMARK 465 LYS B 386 REMARK 465 THR B 387 REMARK 465 THR B 388 REMARK 465 ILE B 389 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1058 O HOH B 973 1456 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 154 CD - NE - CZ ANGL. DEV. = 9.6 DEGREES REMARK 500 ARG A 154 CD - NE - CZ ANGL. DEV. = 11.0 DEGREES REMARK 500 ARG A 154 NE - CZ - NH1 ANGL. DEV. = -7.1 DEGREES REMARK 500 ARG A 154 NE - CZ - NH1 ANGL. DEV. = -7.5 DEGREES REMARK 500 ARG A 154 NE - CZ - NH2 ANGL. DEV. = 6.7 DEGREES REMARK 500 ARG A 154 NE - CZ - NH2 ANGL. DEV. = 7.3 DEGREES REMARK 500 ARG B 154 CD - NE - CZ ANGL. DEV. = 10.0 DEGREES REMARK 500 ARG B 154 CD - NE - CZ ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG B 154 NE - CZ - NH1 ANGL. DEV. = 6.8 DEGREES REMARK 500 ARG B 154 NE - CZ - NH1 ANGL. DEV. = 7.3 DEGREES REMARK 500 ARG B 154 NE - CZ - NH2 ANGL. DEV. = -7.0 DEGREES REMARK 500 ARG B 154 NE - CZ - NH2 ANGL. DEV. = -7.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 11 51.16 -92.25 REMARK 500 PHE A 35 -145.03 -130.20 REMARK 500 ASP A 47 -57.33 70.73 REMARK 500 PHE A 342 3.19 -68.38 REMARK 500 SER A 343 38.12 36.83 REMARK 500 HIS A 345 30.75 -140.54 REMARK 500 ALA B 11 51.04 -91.50 REMARK 500 PHE B 35 -144.92 -129.57 REMARK 500 ASP B 47 -56.60 77.43 REMARK 500 MSE B 302 58.57 -143.26 REMARK 500 SER B 343 36.68 36.44 REMARK 500 HIS B 345 27.25 -142.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 812 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 813 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 814 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTG A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTG B 811 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B3M RELATED DB: PDB REMARK 900 MONOMERIC SARCOSINE OXIDASE: STRUCTURE OF A COVALENTLY FLAVINYLATED REMARK 900 AMINE OXIDIZING ENZYME REMARK 900 RELATED ID: 1EL5 RELATED DB: PDB REMARK 900 MONOMERIC SARCOSINE OXIDASE WITH DIMETHYLGLYCINE REMARK 900 RELATED ID: 1EL7 RELATED DB: PDB REMARK 900 MONOMERIC SARCOSINE OXIDASE WITH [METHYLTELLURO]ACETATE REMARK 900 RELATED ID: 1EL8 RELATED DB: PDB REMARK 900 MONOMERIC SARCOSINE OXIDASE WITH [METHYLSELENO]ACETATE REMARK 900 RELATED ID: 1ELI RELATED DB: PDB REMARK 900 MONOMERIC SARCOSINE OXIDASE WITH PYRROLE-2-CARBOXYLATE DBREF 1EL9 A 1 389 UNP P40859 MSOX_BACB0 2 390 DBREF 1EL9 B 1 389 UNP P40859 MSOX_BACB0 2 390 SEQADV 1EL9 MSE A 14 UNP P40859 MET 15 MODIFIED RESIDUE SEQADV 1EL9 MSE A 16 UNP P40859 MET 17 MODIFIED RESIDUE SEQADV 1EL9 MSE A 105 UNP P40859 MET 106 MODIFIED RESIDUE SEQADV 1EL9 MSE A 201 UNP P40859 MET 202 MODIFIED RESIDUE SEQADV 1EL9 MSE A 245 UNP P40859 MET 246 MODIFIED RESIDUE SEQADV 1EL9 MSE A 302 UNP P40859 MET 303 MODIFIED RESIDUE SEQADV 1EL9 MSE A 316 UNP P40859 MET 317 MODIFIED RESIDUE SEQADV 1EL9 MSE B 14 UNP P40859 MET 15 MODIFIED RESIDUE SEQADV 1EL9 MSE B 16 UNP P40859 MET 17 MODIFIED RESIDUE SEQADV 1EL9 MSE B 105 UNP P40859 MET 106 MODIFIED RESIDUE SEQADV 1EL9 MSE B 201 UNP P40859 MET 202 MODIFIED RESIDUE SEQADV 1EL9 MSE B 245 UNP P40859 MET 246 MODIFIED RESIDUE SEQADV 1EL9 MSE B 302 UNP P40859 MET 303 MODIFIED RESIDUE SEQADV 1EL9 MSE B 316 UNP P40859 MET 317 MODIFIED RESIDUE SEQRES 1 A 389 SER THR HIS PHE ASP VAL ILE VAL VAL GLY ALA GLY SER SEQRES 2 A 389 MSE GLY MSE ALA ALA GLY TYR GLN LEU ALA LYS GLN GLY SEQRES 3 A 389 VAL LYS THR LEU LEU VAL ASP ALA PHE ASP PRO PRO HIS SEQRES 4 A 389 THR ASN GLY SER HIS HIS GLY ASP THR ARG ILE ILE ARG SEQRES 5 A 389 HIS ALA TYR GLY GLU GLY ARG GLU TYR VAL PRO LEU ALA SEQRES 6 A 389 LEU ARG SER GLN GLU LEU TRP TYR GLU LEU GLU LYS GLU SEQRES 7 A 389 THR HIS HIS LYS ILE PHE THR LYS THR GLY VAL LEU VAL SEQRES 8 A 389 PHE GLY PRO LYS GLY GLU SER ALA PHE VAL ALA GLU THR SEQRES 9 A 389 MSE GLU ALA ALA LYS GLU HIS SER LEU THR VAL ASP LEU SEQRES 10 A 389 LEU GLU GLY ASP GLU ILE ASN LYS ARG TRP PRO GLY ILE SEQRES 11 A 389 THR VAL PRO GLU ASN TYR ASN ALA ILE PHE GLU PRO ASN SEQRES 12 A 389 SER GLY VAL LEU PHE SER GLU ASN CYS ILE ARG ALA TYR SEQRES 13 A 389 ARG GLU LEU ALA GLU ALA ARG GLY ALA LYS VAL LEU THR SEQRES 14 A 389 HIS THR ARG VAL GLU ASP PHE ASP ILE SER PRO ASP SER SEQRES 15 A 389 VAL LYS ILE GLU THR ALA ASN GLY SER TYR THR ALA ASP SEQRES 16 A 389 LYS LEU ILE VAL SER MSE GLY ALA TRP ASN SER LYS LEU SEQRES 17 A 389 LEU SER LYS LEU ASN LEU ASP ILE PRO LEU GLN PRO TYR SEQRES 18 A 389 ARG GLN VAL VAL GLY PHE PHE GLU SER ASP GLU SER LYS SEQRES 19 A 389 TYR SER ASN ASP ILE ASP PHE PRO GLY PHE MSE VAL GLU SEQRES 20 A 389 VAL PRO ASN GLY ILE TYR TYR GLY PHE PRO SER PHE GLY SEQRES 21 A 389 GLY CYS GLY LEU LYS LEU GLY TYR HIS THR PHE GLY GLN SEQRES 22 A 389 LYS ILE ASP PRO ASP THR ILE ASN ARG GLU PHE GLY VAL SEQRES 23 A 389 TYR PRO GLU ASP GLU SER ASN LEU ARG ALA PHE LEU GLU SEQRES 24 A 389 GLU TYR MSE PRO GLY ALA ASN GLY GLU LEU LYS ARG GLY SEQRES 25 A 389 ALA VAL CYS MSE TYR THR LYS THR LEU ASP GLU HIS PHE SEQRES 26 A 389 ILE ILE ASP LEU HIS PRO GLU HIS SER ASN VAL VAL ILE SEQRES 27 A 389 ALA ALA GLY PHE SER GLY HIS GLY PHE LYS PHE SER SER SEQRES 28 A 389 GLY VAL GLY GLU VAL LEU SER GLN LEU ALA LEU THR GLY SEQRES 29 A 389 LYS THR GLU HIS ASP ILE SER ILE PHE SER ILE ASN ARG SEQRES 30 A 389 PRO ALA LEU LYS GLU SER LEU GLN LYS THR THR ILE SEQRES 1 B 389 SER THR HIS PHE ASP VAL ILE VAL VAL GLY ALA GLY SER SEQRES 2 B 389 MSE GLY MSE ALA ALA GLY TYR GLN LEU ALA LYS GLN GLY SEQRES 3 B 389 VAL LYS THR LEU LEU VAL ASP ALA PHE ASP PRO PRO HIS SEQRES 4 B 389 THR ASN GLY SER HIS HIS GLY ASP THR ARG ILE ILE ARG SEQRES 5 B 389 HIS ALA TYR GLY GLU GLY ARG GLU TYR VAL PRO LEU ALA SEQRES 6 B 389 LEU ARG SER GLN GLU LEU TRP TYR GLU LEU GLU LYS GLU SEQRES 7 B 389 THR HIS HIS LYS ILE PHE THR LYS THR GLY VAL LEU VAL SEQRES 8 B 389 PHE GLY PRO LYS GLY GLU SER ALA PHE VAL ALA GLU THR SEQRES 9 B 389 MSE GLU ALA ALA LYS GLU HIS SER LEU THR VAL ASP LEU SEQRES 10 B 389 LEU GLU GLY ASP GLU ILE ASN LYS ARG TRP PRO GLY ILE SEQRES 11 B 389 THR VAL PRO GLU ASN TYR ASN ALA ILE PHE GLU PRO ASN SEQRES 12 B 389 SER GLY VAL LEU PHE SER GLU ASN CYS ILE ARG ALA TYR SEQRES 13 B 389 ARG GLU LEU ALA GLU ALA ARG GLY ALA LYS VAL LEU THR SEQRES 14 B 389 HIS THR ARG VAL GLU ASP PHE ASP ILE SER PRO ASP SER SEQRES 15 B 389 VAL LYS ILE GLU THR ALA ASN GLY SER TYR THR ALA ASP SEQRES 16 B 389 LYS LEU ILE VAL SER MSE GLY ALA TRP ASN SER LYS LEU SEQRES 17 B 389 LEU SER LYS LEU ASN LEU ASP ILE PRO LEU GLN PRO TYR SEQRES 18 B 389 ARG GLN VAL VAL GLY PHE PHE GLU SER ASP GLU SER LYS SEQRES 19 B 389 TYR SER ASN ASP ILE ASP PHE PRO GLY PHE MSE VAL GLU SEQRES 20 B 389 VAL PRO ASN GLY ILE TYR TYR GLY PHE PRO SER PHE GLY SEQRES 21 B 389 GLY CYS GLY LEU LYS LEU GLY TYR HIS THR PHE GLY GLN SEQRES 22 B 389 LYS ILE ASP PRO ASP THR ILE ASN ARG GLU PHE GLY VAL SEQRES 23 B 389 TYR PRO GLU ASP GLU SER ASN LEU ARG ALA PHE LEU GLU SEQRES 24 B 389 GLU TYR MSE PRO GLY ALA ASN GLY GLU LEU LYS ARG GLY SEQRES 25 B 389 ALA VAL CYS MSE TYR THR LYS THR LEU ASP GLU HIS PHE SEQRES 26 B 389 ILE ILE ASP LEU HIS PRO GLU HIS SER ASN VAL VAL ILE SEQRES 27 B 389 ALA ALA GLY PHE SER GLY HIS GLY PHE LYS PHE SER SER SEQRES 28 B 389 GLY VAL GLY GLU VAL LEU SER GLN LEU ALA LEU THR GLY SEQRES 29 B 389 LYS THR GLU HIS ASP ILE SER ILE PHE SER ILE ASN ARG SEQRES 30 B 389 PRO ALA LEU LYS GLU SER LEU GLN LYS THR THR ILE MODRES 1EL9 MSE A 14 MET SELENOMETHIONINE MODRES 1EL9 MSE A 16 MET SELENOMETHIONINE MODRES 1EL9 MSE A 105 MET SELENOMETHIONINE MODRES 1EL9 MSE A 201 MET SELENOMETHIONINE MODRES 1EL9 MSE A 245 MET SELENOMETHIONINE MODRES 1EL9 MSE A 302 MET SELENOMETHIONINE MODRES 1EL9 MSE A 316 MET SELENOMETHIONINE MODRES 1EL9 MSE B 14 MET SELENOMETHIONINE MODRES 1EL9 MSE B 16 MET SELENOMETHIONINE MODRES 1EL9 MSE B 105 MET SELENOMETHIONINE MODRES 1EL9 MSE B 201 MET SELENOMETHIONINE MODRES 1EL9 MSE B 245 MET SELENOMETHIONINE MODRES 1EL9 MSE B 302 MET SELENOMETHIONINE MODRES 1EL9 MSE B 316 MET SELENOMETHIONINE HET MSE A 14 8 HET MSE A 16 8 HET MSE A 105 8 HET MSE A 201 8 HET MSE A 245 8 HET MSE A 302 8 HET MSE A 316 8 HET MSE B 14 8 HET MSE B 16 8 HET MSE B 105 8 HET MSE B 201 8 HET MSE B 245 8 HET MSE B 302 8 HET MSE B 316 8 HET PO4 A 803 5 HET CL A 804 1 HET FAD A 400 53 HET MTG A 801 6 HET PO4 B 812 5 HET PO4 B 813 5 HET CL B 814 1 HET FAD B 400 53 HET MTG B 811 6 HETNAM MSE SELENOMETHIONINE HETNAM PO4 PHOSPHATE ION HETNAM CL CHLORIDE ION HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM MTG [METHYLTHIO]ACETATE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 PO4 3(O4 P 3-) FORMUL 4 CL 2(CL 1-) FORMUL 5 FAD 2(C27 H33 N9 O15 P2) FORMUL 6 MTG 2(C3 H5 O2 S 1-) FORMUL 12 HOH *552(H2 O) HELIX 1 1 GLY A 12 GLN A 25 1 14 HELIX 2 2 GLY A 58 GLU A 60 5 3 HELIX 3 3 TYR A 61 THR A 79 1 19 HELIX 4 4 SER A 98 HIS A 111 1 14 HELIX 5 5 GLY A 120 TRP A 127 1 8 HELIX 6 6 PHE A 148 ARG A 163 1 16 HELIX 7 7 MSE A 201 ALA A 203 5 3 HELIX 8 8 TRP A 204 LEU A 209 1 6 HELIX 9 9 SER A 210 LEU A 212 5 3 HELIX 10 10 ASP A 231 SER A 236 1 6 HELIX 11 11 ASN A 237 ASP A 240 5 4 HELIX 12 12 PRO A 288 MSE A 302 1 15 HELIX 13 13 PRO A 303 ASN A 306 5 4 HELIX 14 14 GLY A 346 LYS A 348 5 3 HELIX 15 15 PHE A 349 GLY A 364 1 16 HELIX 16 16 ILE A 370 SER A 374 5 5 HELIX 17 17 ARG A 377 LYS A 381 5 5 HELIX 18 18 GLY B 12 GLN B 25 1 14 HELIX 19 19 GLY B 58 GLU B 60 5 3 HELIX 20 20 TYR B 61 THR B 79 1 19 HELIX 21 21 SER B 98 HIS B 111 1 14 HELIX 22 22 GLY B 120 TRP B 127 1 8 HELIX 23 23 PHE B 148 ARG B 163 1 16 HELIX 24 24 MSE B 201 ALA B 203 5 3 HELIX 25 25 TRP B 204 LEU B 209 1 6 HELIX 26 26 SER B 210 LEU B 212 5 3 HELIX 27 27 ASP B 231 SER B 236 1 6 HELIX 28 28 ASN B 237 ASP B 240 5 4 HELIX 29 29 PRO B 288 MSE B 302 1 15 HELIX 30 30 PRO B 303 ASN B 306 5 4 HELIX 31 31 GLY B 346 LYS B 348 5 3 HELIX 32 32 PHE B 349 GLY B 364 1 16 HELIX 33 33 ILE B 370 SER B 374 5 5 HELIX 34 34 ARG B 377 LYS B 381 5 5 SHEET 1 A 6 ILE A 326 HIS A 330 0 SHEET 2 A 6 HIS A 333 ALA A 340 -1 N HIS A 333 O HIS A 330 SHEET 3 A 6 GLY A 190 VAL A 199 1 O LEU A 197 N VAL A 337 SHEET 4 A 6 PHE A 4 VAL A 9 1 N PHE A 4 O THR A 193 SHEET 5 A 6 THR A 29 VAL A 32 1 O LEU A 30 N VAL A 8 SHEET 6 A 6 LYS A 166 LEU A 168 1 O LYS A 166 N LEU A 31 SHEET 1 B 5 ILE A 326 HIS A 330 0 SHEET 2 B 5 HIS A 333 ALA A 340 -1 N HIS A 333 O HIS A 330 SHEET 3 B 5 GLY A 190 VAL A 199 1 O LEU A 197 N VAL A 337 SHEET 4 B 5 SER A 182 THR A 187 -1 N VAL A 183 O ALA A 194 SHEET 5 B 5 VAL A 173 SER A 179 -1 N GLU A 174 O GLU A 186 SHEET 1 C 3 ARG A 49 ILE A 51 0 SHEET 2 C 3 GLY A 145 LEU A 147 -1 O GLY A 145 N ILE A 51 SHEET 3 C 3 PHE A 84 THR A 85 -1 O THR A 85 N VAL A 146 SHEET 1 D 8 LEU A 309 LYS A 319 0 SHEET 2 D 8 GLN A 219 PHE A 228 -1 O GLN A 219 N LYS A 319 SHEET 3 D 8 LEU A 264 TYR A 268 -1 O LEU A 264 N PHE A 228 SHEET 4 D 8 GLY A 251 PHE A 256 -1 O TYR A 254 N GLY A 267 SHEET 5 D 8 GLY A 243 VAL A 248 -1 O PHE A 244 N GLY A 255 SHEET 6 D 8 VAL A 89 PRO A 94 1 N LEU A 90 O GLY A 243 SHEET 7 D 8 TYR A 136 GLU A 141 -1 N ASN A 137 O GLY A 93 SHEET 8 D 8 ASP A 116 GLU A 119 -1 O ASP A 116 N PHE A 140 SHEET 1 E 3 LEU A 309 LYS A 319 0 SHEET 2 E 3 GLN A 219 PHE A 228 -1 O GLN A 219 N LYS A 319 SHEET 3 E 3 GLN A 273 LYS A 274 -1 O GLN A 273 N ARG A 222 SHEET 1 F 2 LEU A 214 ASP A 215 0 SHEET 2 F 2 SER A 383 LEU A 384 -1 O SER A 383 N ASP A 215 SHEET 1 G 6 ILE B 326 HIS B 330 0 SHEET 2 G 6 HIS B 333 ALA B 340 -1 N HIS B 333 O HIS B 330 SHEET 3 G 6 GLY B 190 VAL B 199 1 O LEU B 197 N VAL B 337 SHEET 4 G 6 THR B 2 VAL B 9 1 O THR B 2 N THR B 193 SHEET 5 G 6 THR B 29 VAL B 32 1 O LEU B 30 N VAL B 8 SHEET 6 G 6 LYS B 166 LEU B 168 1 O LYS B 166 N LEU B 31 SHEET 1 H 5 ILE B 326 HIS B 330 0 SHEET 2 H 5 HIS B 333 ALA B 340 -1 N HIS B 333 O HIS B 330 SHEET 3 H 5 GLY B 190 VAL B 199 1 O LEU B 197 N VAL B 337 SHEET 4 H 5 SER B 182 THR B 187 -1 N VAL B 183 O ALA B 194 SHEET 5 H 5 PHE B 176 SER B 179 -1 N ASP B 177 O LYS B 184 SHEET 1 I 3 ARG B 49 ILE B 51 0 SHEET 2 I 3 GLY B 145 LEU B 147 -1 O GLY B 145 N ILE B 51 SHEET 3 I 3 PHE B 84 THR B 85 -1 O THR B 85 N VAL B 146 SHEET 1 J 8 LEU B 309 LYS B 319 0 SHEET 2 J 8 GLN B 219 PHE B 228 -1 O GLN B 219 N LYS B 319 SHEET 3 J 8 LEU B 264 TYR B 268 -1 O LEU B 264 N PHE B 228 SHEET 4 J 8 GLY B 251 PHE B 256 -1 O TYR B 254 N GLY B 267 SHEET 5 J 8 GLY B 243 VAL B 248 -1 O PHE B 244 N GLY B 255 SHEET 6 J 8 VAL B 89 PRO B 94 1 N LEU B 90 O GLY B 243 SHEET 7 J 8 TYR B 136 GLU B 141 -1 N ASN B 137 O GLY B 93 SHEET 8 J 8 ASP B 116 GLU B 119 -1 O ASP B 116 N PHE B 140 SHEET 1 K 3 LEU B 309 LYS B 319 0 SHEET 2 K 3 GLN B 219 PHE B 228 -1 O GLN B 219 N LYS B 319 SHEET 3 K 3 GLN B 273 LYS B 274 -1 O GLN B 273 N ARG B 222 SHEET 1 L 2 LEU B 214 ASP B 215 0 SHEET 2 L 2 SER B 383 LEU B 384 -1 O SER B 383 N ASP B 215 LINK SG CYS A 315 C8M FAD A 400 1555 1555 1.82 LINK SG CYS B 315 C8M FAD B 400 1555 1555 1.80 LINK C SER A 13 N MSE A 14 1555 1555 1.33 LINK C MSE A 14 N GLY A 15 1555 1555 1.33 LINK C GLY A 15 N MSE A 16 1555 1555 1.33 LINK C MSE A 16 N ALA A 17 1555 1555 1.33 LINK C THR A 104 N MSE A 105 1555 1555 1.33 LINK C MSE A 105 N GLU A 106 1555 1555 1.33 LINK C SER A 200 N MSE A 201 1555 1555 1.33 LINK C MSE A 201 N GLY A 202 1555 1555 1.33 LINK C PHE A 244 N MSE A 245 1555 1555 1.33 LINK C MSE A 245 N VAL A 246 1555 1555 1.32 LINK C TYR A 301 N MSE A 302 1555 1555 1.33 LINK C MSE A 302 N PRO A 303 1555 1555 1.35 LINK C CYS A 315 N MSE A 316 1555 1555 1.34 LINK C MSE A 316 N TYR A 317 1555 1555 1.33 LINK C SER B 13 N MSE B 14 1555 1555 1.33 LINK C MSE B 14 N GLY B 15 1555 1555 1.32 LINK C GLY B 15 N MSE B 16 1555 1555 1.33 LINK C MSE B 16 N ALA B 17 1555 1555 1.33 LINK C THR B 104 N MSE B 105 1555 1555 1.33 LINK C MSE B 105 N GLU B 106 1555 1555 1.33 LINK C SER B 200 N MSE B 201 1555 1555 1.32 LINK C MSE B 201 N GLY B 202 1555 1555 1.34 LINK C PHE B 244 N MSE B 245 1555 1555 1.33 LINK C MSE B 245 N VAL B 246 1555 1555 1.33 LINK C TYR B 301 N MSE B 302 1555 1555 1.33 LINK C MSE B 302 N PRO B 303 1555 1555 1.35 LINK C CYS B 315 N MSE B 316 1555 1555 1.33 LINK C MSE B 316 N TYR B 317 1555 1555 1.33 CISPEP 1 PRO A 37 PRO A 38 0 -0.14 CISPEP 2 PRO B 37 PRO B 38 0 -0.26 SITE 1 AC1 4 HIS A 81 ASN A 151 ARG A 154 HOH A 846 SITE 1 AC2 5 TYR A 317 THR A 318 GLY A 344 FAD A 400 SITE 2 AC2 5 HOH A 825 SITE 1 AC3 8 HIS B 53 LEU B 113 THR B 114 GLU B 141 SITE 2 AC3 8 PRO B 142 ASN B 143 SER B 144 HOH B 903 SITE 1 AC4 5 HIS B 81 ASN B 151 ARG B 154 HOH B 819 SITE 2 AC4 5 HOH B1017 SITE 1 AC5 5 TYR B 317 THR B 318 GLY B 344 FAD B 400 SITE 2 AC5 5 HOH B 824 SITE 1 AC6 39 GLY A 10 GLY A 12 SER A 13 MSE A 14 SITE 2 AC6 39 VAL A 32 ASP A 33 ALA A 34 PHE A 35 SITE 3 AC6 39 HIS A 39 GLY A 42 SER A 43 HIS A 44 SITE 4 AC6 39 ARG A 49 ILE A 50 THR A 171 ARG A 172 SITE 5 AC6 39 VAL A 173 SER A 200 MSE A 201 GLY A 202 SITE 6 AC6 39 TRP A 204 VAL A 225 TYR A 254 CYS A 315 SITE 7 AC6 39 MSE A 316 TYR A 317 PHE A 342 GLY A 344 SITE 8 AC6 39 HIS A 345 GLY A 346 PHE A 347 LYS A 348 SITE 9 AC6 39 MTG A 801 CL A 804 HOH A 810 HOH A 813 SITE 10 AC6 39 HOH A 815 HOH A 847 HOH A 853 SITE 1 AC7 9 ILE A 50 ARG A 52 MSE A 245 TYR A 254 SITE 2 AC7 9 HIS A 269 TYR A 317 GLY A 344 LYS A 348 SITE 3 AC7 9 FAD A 400 SITE 1 AC8 39 GLY B 10 GLY B 12 SER B 13 MSE B 14 SITE 2 AC8 39 VAL B 32 ASP B 33 ALA B 34 PHE B 35 SITE 3 AC8 39 HIS B 39 GLY B 42 SER B 43 HIS B 44 SITE 4 AC8 39 ARG B 49 ILE B 50 THR B 171 ARG B 172 SITE 5 AC8 39 VAL B 173 SER B 200 MSE B 201 GLY B 202 SITE 6 AC8 39 TRP B 204 VAL B 225 TYR B 254 CYS B 315 SITE 7 AC8 39 MSE B 316 TYR B 317 PHE B 342 GLY B 344 SITE 8 AC8 39 HIS B 345 GLY B 346 PHE B 347 LYS B 348 SITE 9 AC8 39 MTG B 811 CL B 814 HOH B 817 HOH B 822 SITE 10 AC8 39 HOH B 823 HOH B 826 HOH B 830 SITE 1 AC9 9 ILE B 50 ARG B 52 MSE B 245 TYR B 254 SITE 2 AC9 9 HIS B 269 TYR B 317 GLY B 344 LYS B 348 SITE 3 AC9 9 FAD B 400 CRYST1 72.762 69.587 73.765 90.00 94.02 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013743 0.000000 0.000966 0.00000 SCALE2 0.000000 0.014371 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013590 0.00000 MASTER 365 0 23 34 54 0 35 6 0 0 0 60 END